Hantaviruses

Current Opinion in Infectious Diseases

Volumn 10, Issue 5, 1997, Pages 362-366

  Glass, Gregory E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HAPLOTYPE; HUMAN; MOLECULAR BIOLOGY; REVIEW; SOUTH AMERICA; UNITED STATES; VIRUS TRANSMISSION;

EID: 0030875447     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199710000-00007     Document Type: Review

References (32)

1. Parisi M, Enria D, Pini NC, Sabatini MS: Detection retrospectiva de infecciones clinicas por hantavirus en la Argentina. Medicina (Buenos Aires) 1995, 56:1-13.
2. Williams RJ, Bryan RT, Mills JN, Palma E, Vera I et al.: Hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg 1996, 55(Suppl):107 (abstract no. 30).
3. Iversson LB, Branquinho MS, Rosa MD: Serological survey on Hantavirus human infection in Juquitiba state of Sao Paulo, Brazil. Am J Trop Med Hyg 1995, 53 (Suppl):232 (abstract no. 439).
4. Wu T-N, Chin C, Shen C-Y, Chang P-Y: Hantavirus infection in Taiwan. Lancet 1996, 347:770-771.
5. Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield LM, Ksiazek TG, Rollin PE, Peters CJ, Khabbaz RF: Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993. Arch Pathol Lab Med 1996, 120:134-139. A retrospective survey using materials of 82 patients who died before 1993, but meeting the Centers for Disease Control and Prevention case definition for HPS, were tested by immunohistochemistry. Twelve were positive for SNV antigen. The earliest documented case was in 1978.
6. White DJ, Means RG, Birkhead GS, Bosler EM, Grady LJ, Chatterjee N, Woodall J, Hjelle B, Rollin PE, Ksiazek TG, Morse DL: Human and rodent hantavirus infection in New York State. Arch Intern Med 1996, 156:722-726.
7. Song J-W, Baek LJ, Nagle JW, Schlitter D, Yanagihara R: Genetic and phylogenetic analyses of hantaviral sequences amplified from archival tissues of deer mice (Peromyscus maniculatus nubiterrae) captured in the eastern United States. Arch Virol 1996, 141: 959-967.
8. Jay M, Hjelle B, Davis R, Ascher M, Baylies HN: Occupational exposure leading to hantavirus pulmonary syndrome in a utility company employee. Clin Infect Dis 1996, 22:841-844.
9. Vitek CR, Breiman RF, Ksiazek TG, Rollin PE, McLaughlin JC, Umland ET, Nolte KB, Loera A, Sewell, Peters CJ: Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 1996, 22:824-826. A serosurvey of 396 healthcare workers in the southwestern USA, of whom 67% had self-reported exposure to HPS patients or their body fluids. None of the workers had IgM or IgG antibodies to SNV even though 27% reported some symptoms of illness. The study indicates that transmission is unlikely in healthcare settings.
10. Vitek CR, Ksiazek TG, Peters CJ, Robert F, Breiman RF: Evidence against infection with hantaviruses among forest and park workers in the southwestern United States. Clin Infect Dis 1996, 23:283-285. A serosurvey of 140 workers with occupations likely to lead to exposure to hantavirus was conducted. Of those, 89 had repeated exposures to rodents, their feces and nests. None of the individuals were seropositive to SNV indicating that risk in these occupational settings was low.
11. Enria D, Padula P, Segura EL, Pini N, Edelstein A, Riva Posse C, Weissenbacher MC: Hantavirus pulmonary syndrome in Argentina possibility of person-to-person transmission. Medicina (Buenos Aires) 1996, 56:709-711. A case series investigation of HPS in southwestern Argentina with evidence of person-to-person transmission.
12. Wells RM, Estani SS, Yadon ZE, Enria D, Padula P, Pini N, Mills JN, Peters CJ, Segura EL, Guthmann N et al.: An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg Infect Dis 1997, 3:171-174. Report of the southwestern Argentina outbreak with additional information on the epidemiology and epizootiology of the cases.
13. Hutchinson KL, Peters CJ, Nichol ST: Sin Nombre virus messenger-RNA synthesis. Virology 1996, 224:139-149. A study of SNV mRNA replication timing and strategies for S, M, and L segments performed in vitro. Each segment differs in mRNA termination mechanism and mRNA from each segment accumulates at significantly different rates.
14. Frese M, Kochs G, Feldmann H, Hertkorn C, Haller O: Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 1996, 70:915-923. Analysis shows that MxA protein inhibits replication of Hantaan virus in Vero cells early in the virus replication cycle. It has a similar effect on Puumala virus but it is noted in the discussion section that MxA in monocytes does not inhibit Puumala virus S segment replication.
15. Liang MF, Chu YK, Schmaljohn CS: Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology 1996, 217:262-271. Bacterial expression of Fab fragments of monoclonal antibodies to G1 and G2 were able to neutralize virus in vitro but did protect animals against challenge.
16. Henderson WW, Monroe MC, St Jeor SC, Thayer WP, Rowe JE, Peters CJ, Nichol ST: Naturally occurring Sin Nombre virus genetic reassortants. Virology 1995, 214:602-610.
17. Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, Strine T, Miller G, Reef S, Tappero J et al.: Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996, 173:1297-1303. A detailed review of the case series of HPS in the USA to December 1994 describing the epidemiology and epizootiology of the disease, and diagnosis. It also includes historical cases preceding the 1993 outbreak.
18. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, Levy H: Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996, 24:252-258. A description of a series of 14 patients with HPS characterizing the pulmonary pathophysiological changes associated with disease.
19. Khan AS, Gaviria M, Rollin PE, Hlady WG, Ksiazek TG, Armstrong LR, Greenman R, Ravkov E, Kolber M, Anapol H et al: Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med 1996, 100:46-48. Case description of HPS associated with Black Creek Canal virus notable for the inclusion of renal involvement in its presentation which differed markedly from 'typical' HPS.
20. Hoffman WW, Henrickson RG, Wengs WJ, Crump JW, Keppen M, Carpenter PL, Webb D, Reiffenberger S, Bleeker B, Ostby JR et al.: Hantavirus pulmonary syndrome - United States, 1995 and 1996. JAMA 1996, 275:1395-1397.
21. Butler JC, Peters CJ: Lessons learned from the hantaviruses and other hemorrhagic fever viruses. Am J Med Sci 1996, 311:55-59.
22. Hjelle B, Goade D, Torrez-Martinez N, Lang-Williams M, Kim J, Harris RL, Rawlings JA: Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 1996, 23:495-500. A clinical description of HPS associated with Bayou virus indicating that renal insufficiency may also be evident with this infection.
23. Armstrong LR, Bryan RT, Sarisky J, Khan AS, Rowe T, Ettestad PJ, Cheek JE, Peters CJ, Rollin P, Martin ML, Ksiazek TG: Mild hantaviral disease caused by Sin Nombre virus in a 4-year-old child. Pediatr Infect Dis J 1995, 14:1108-1110.
24. Mustonen J, Partanen J, Kanerva M, Pietila K, Vapalahti O, Pasernack A, Vaheri A: Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 1996, 49: 217-221. In 74 adult patients with nephropathia epidemica there was an increased prevalence of individuals with B8 and DRB1*0301 haplotypes among those with the most severe disease. The workers were able to rule out other predisposing illnesses for the observations, and suggest that disease severity may be affected by human genetic background.
25. Linderholm M, Groeneveld PHP, Tarnvik A: Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome - relation to arterial hypotension and tumor necrosis factor. Infection 1996, 24:337-340. In 15 consecutive patients with nephropathia epidemica there was a positive correlation between the degree of hypotension and the levels of nitrate plus nitrite, as a measure of nitric oxide and tumor necrosis factor, patterns consistent with the physiological action of nitric oxide.
26. Linderholm M, AhIm C, Settergren B, Waage A, Tarnvik A: Elevated plasma levels of tumor necrosis factor (TNF-)α, soluble TNF receptors, interleukin (IL-)6, and IL-1 - in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 173:38-43.
27. Hjelle B, Torrez-Martinez N, Koster FT: Hantavirus pulmonary syndrome-related virus from Bolivia [Letter]. Lancet 1996, 347:57.
28. Levis S, Rowe JE, Morzunov S, Enria DA, St Jeor S: New hantaviruses causing hantavirus pulmonary syndrome in central Argentina. Lancet 1997, 349:998-999.
29. Antoniadis A, Stylianakis A, Papa A, Alexiondaniel S, Lampropoulos A, Nichol ST, Peters CJ, Spiropoulou CF: Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 174:407-410.
30. Horling J, Chizhikov V, Lundkvist A, Johsson M, Ivanov L, Dekonenko A, Niklasson B, Dzagurova T, Peters CJ, Tkachenko E, Nichol S: Khabarovsk virus: a phylogenetically and serologically distinct Hantavirus isolated from Microtus fortis trapped in far-east Russia. J Gen Virol 1996, 77:687-694.
31. Lopez N, Padula P, Rossi C, Lazario ME, Franze-Fernandez MT: Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220:223-226. The first genetic characterization of a South American hantavirus associated with fatal HPS, showing its relationship to US sigmodontine hantaviruses.
32. Mills JN, Ksiazek TG, Ellis BA, Rollin PE, Nichol ST, Yates TL, Gannon WL, Levy CE, Engelthaler DM, Davis T et al.: Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg 1997, 56:273-284. A detailed survey of the small mammal fauna of the southwestern USA for antibodies to SNV. Results show that antibodies are restricted to murid rodents, are widespread in reservoir species and increase primarily in older male rodents. Habitat differences in seroprevalence are characterized.